Search for: "Schering AG" Results 41 - 60 of 89
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2009, 2:20 am
" Schering-Plough Corp.'s Marvelon and Cerazette pills, which contain desogestrel, generated $319 million for the Kenilworth, New Jersey-based company in the first quarter, IMS Health data show. [read post]
16 Sep 2009, 1:38 pm
Franz-Josef Renneke -- who is the Site Manager for  Bayer HealthCare - Bayer Schering Pharma AG at its manufacturing facility in  Bergkamen, Germany. [read post]
9 Dec 2009, 2:00 pm
The pharmaceuticals business operates under the name Bayer Schering Pharma and as Bayer HealthCare Pharmaceuticals in the US and Canada. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
26 Nov 2007, 3:06 pm
The October 2007 FDA staff report was prepared in advance of a meeting of an advisory panel of pediatricians later this week being convened to consider the safety of Serevent and Advair (made by GlaxoSmithKline PLC), both of which contain the active ingredient salmeterol, as well as another asthma drug, Foradil (made by Novartis AG and marketed in the U.S. by Schering-Plough Corp.), which contains the active ingredient formoterol. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Bayer AG (FDA Law Blog) (Patent Docs) Melatonin – EWCA refers SPC questions to the ECJ: Neurim Pharmaceuticals (1991) Ltd v Comptroller General of Patents (The SPC Blog) (The SPC Blog) (EPLAW) (IPKat) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  This sort of arrangement has been referred to as a “No AG” (i.e., no authorized generic) agreement. [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
He signed his first client at age 22 while a student at Duke University Law School. [read post]
22 Apr 2014, 11:29 pm by Lawrence B. Ebert
The infringement occursonly if the generic company seeks approval for a patentedcomposition or use that has been approved by the FDA.Bayer Schering Pharma AG v. [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Infosint (IPKat) (PatLit) Clobex (Clobetasol) – US: Galderma, Dermalogix agree to end Clobex suit with Paddock (Patent Docs) Crestor (Rosuvastatin) – US: Palmetto files patent infringement suit against AstraZeneca based on its Crestor product; AstraZeneca files for declaratory judgment of non-infringement and invalidity (Patent Docs) Drospirenone, Ethinylestradiol – UK: Shedding further light on obviousness: Gedeon Richter PC v Bayer Schering Pharma AG (Kluwer… [read post]
6 Oct 2010, 12:54 am by Matthew Hill
The BBC had made submissions on this point, based on the case of Schering Chemicals Ltd v Falkman Ltd [1982] 1 QB 1. [read post]
24 Apr 2007, 1:04 am
Court Refuses to Revive Smoking Suit Filed Years After Limitations Period New York Law Journal A man who began smoking at age 9 and did not quit until he underwent cancer surgery 30 years later is time-barred from suing cigarette companies for his disease, a New York court has ruled. [read post]